Louis Lehot on Biotech IPOs – 'Biotech could have a great fourth quarter'
September 4, 2024
Bloomberg Law
Foley & Lardner LLP partner Louis Lehot offered insight on the biotech industry’s upcoming initial public offerings in the Bloomberg Law article, “Biotech IPO Hopefuls Ready Burst of Debuts After Rough Stretch.”
“Biotech could have a great fourth quarter, we have a great pipeline,” Lehot commented, as several biotech companies look to reignite the sector with upcoming IPOs. “Biotech IPOs are here and ready to put money to work.”
(Subscription required)
People
Related News
August 5, 2026
In the News
Gregory Husisian Weighs In on CBP Refund Process
Foley & Lardner LLP partner Gregory Husisian was quoted in Newsweek addressing the performance of the Customs and Border Protection (CBP) refunds process.
August 4, 2026
In the News
Foley’s Miami Office Move Featured in Law.com
Foley & Lardner LLP’s Miami office is featured for its relocation in the Law.com article, “After 18 Years in Miami, Foley & Lardner Relocates to Southeast Financial Center.”
August 4, 2026
In the News
Daniel Farris and Rachel Conrad Author Article on How Powered Land Is Reshaping Data Center Development
Foley & Lardner LLP attorneys Daniel Farris and Rachel Conrad authored the Environment + Energy Leader article, “How Powered Land Is Changing Data Center Site Selection,” analyzing the central role of power availability in the evolving process of data center site selection.